More articles from Novel Strategies for Cancer Vaccines

You have accessRestricted access
The QuickSwitch Quant HLA-A*02:01 Tetramer Kit can be used for determining the biological activity of a cancer vaccine.
Marc C Delcommenne, Olga Hrytsenko, Cynthia Tram, Genevieve Weir and Marianne M. Stanford

J Immunol 198 (1 Supplement) 79.27; May 1, 2017,
You have accessRestricted access
New strategies in vaccine design for the induction of CD8 T cell responses using biodegradable iron oxide nanoparticles
Liam M Powles, Kirsty Wilson, Sue D Xiang, Cordelia Selomulya and Magdalena Plebanski

J Immunol 198 (1 Supplement) 79.23; May 1, 2017,
You have accessRestricted access
Radiation Therapy and Talimogene Laherparepvec (TVEC) Synergize in the Treatment of Melanoma
Sachin R Jhawar, Sharad Goyal, Aditya Thandoni, Praveen Bommareddy, Suemair Hassan, Devora Schiff, Bruce G Haffty, Howard Kaufman and Andrew Zloza

J Immunol 198 (1 Supplement) 79.32; May 1, 2017,
You have accessRestricted access
Entolimod, a clinical-stage TLR5 agonist, activates antitumor T cell immunity against liver and lung metastases through distinct mechanisms
Craig M Brackett, Bojidar Kojouharov, Kellee Greene, Nicholas Trageser, Sandra Gollnick, Lyudmila Burdelya, Scott I Abrams and Andrei Gudkov

J Immunol 198 (1 Supplement) 79.12; May 1, 2017,
You have accessRestricted access
Development of therapeutics to maintain vaccine immunity following exposure to ionizing radiation.
Hugh I McFarland, Ryan T Surujdin, Joseph Aryankalayil, Julia D. Berkson, Jay P. Lee and Amy S. Rosenberg

J Immunol 198 (1 Supplement) 79.30; May 1, 2017,
You have accessRestricted access
Development of a curative therapeutic vaccine (TheraVac) for the treatment of large established tumors
De Yang, Yingjie Nie, Anna L Trivett, Zhen Han, Xin Chen and Joost J Oppenheim

J Immunol 198 (1 Supplement) 79.20; May 1, 2017,
You have accessRestricted access
Genetic linkage analysis of cancer vaccine response in Diversity Outbred mice
Heather Gibson, Joyce Reyes, Richard Jones, Greg Dyson and Wei-Zen Wei

J Immunol 198 (1 Supplement) 79.29; May 1, 2017,
You have accessRestricted access
Targeting adenosine A2A receptors to improve vaccine efficacy
Caglar Cekic, Ali Can Savas, Merve Kayhan, Altay Koyas and Imran Akdemir

J Immunol 198 (1 Supplement) 79.22; May 1, 2017,
You have accessRestricted access
Efficacy of combining radiotherapy and immunotherapy for metastatic colorectal cancer and the modulation of tumor microenvironment
Chia-Jen Wu, Yi-Ting Tsai, Ching-Cheng Chang, I-Jung Lee, Ping-Yi Wu and Mi-Hua Tao

J Immunol 198 (1 Supplement) 79.15; May 1, 2017,
You have accessRestricted access
Dual antigen transfer pathways mediate highly efficacious anti-tumor immunity induced by intravenously injected antigen-loaded monocytes
Min-Nung Huang, Lowell Nicholson, Kristen Batich, David Kopin, Vijay Prabhakar, Barbara Lipes, John Sampson and Michael Gunn

J Immunol 198 (1 Supplement) 79.21; May 1, 2017,

Main menu

User menu

Search

More articles from Novel Strategies for Cancer Vaccines

Pages

Navigate

For Authors

General Information

Journal Services